HTA in EU: multiparty early dialogue pilot takes shape, launch due in 2014
This article was originally published in Clinica
Executive Summary
The European Commission is to invite drug and medical device companies with development-stage products to engage in early health technology assessment (HTA) dialogue with a group comprising HTA bodies from at least 10 EU member states under a new pilot project.